CADISTA HOLDINGS INC. FILES (8-K) Disclosing Change in Directors or Principal Officers, Financial Statements and Exhibits
(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02 Departure of Directors or Principal Officers, Election of Directors,
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 6, 2014, our subsidiary, Jubilant Cadista Pharmaceuticals, Inc.
("JCPI" or the "Company") and Scott Delaney ("Delaney") its and our Chief
Executive Officer entered into an Amended and Restated Employment Agreement (the
"Amendment"), amending his Employment Agreement dated April 2, 2009, as amended
effective as of May 1, 2012 (the "Employment Agreement"). The Amendment is
effective as of July 1, 2014 and contains the following changes, among others:
· provides that Mr. Delaney will continue to be employed as the Chief Executive
Officer of JCPI and extends the term of the Employment Agreement until July 1,
2018 (it was scheduled to expire on June 30, 2015).
· increases Mr. Delaney's salary to $385,000 effective July 1, 2014 (increased
from $327,600), and provides that the salary will be reviewed on an annual
· provides for a retention bonus of two-hundred and seventy-five thousand dollars
($275,000) if Mr. Delaney is employed by JCPI continuously from July 1, 2014
through June 30, 2018.
· provides for the immediate payment of $100,000 of a $150,000 retention bonus
that otherwise was payable on July 1, 2015 if Delaney was employed on that date
by JCPI, and eliminates the last $50,000 payment of such retention bonus, which
is now part of the aforementioned $275,000 retention bonus.
· provides for a bonus of twenty five thousand dollars ($25,000) for signing the
Amendment payable July 31, 2015 provided that if Mr. Delaney leaves JCPI prior
to July 1, 2015, this bonus will not be paid.
· continues to provide that Mr. Delaney receives medical, dental and vision
health benefits for himself and immediate family members as approved by the
Board and made generally available to the Company's senior management, but
removes the limit on the maximum cost to the Company.
· continues to provide that Mr. Delaney is eligible to participate in the
Company's 401(k) plan but increases the Company's match from up to 2% to up to
3% of his annual base salary.
· provides that for 24 months (increased from 12 months in the Employment
Agreement) after termination he will not solicit persons for generic
pharmaceutical sales who were JCPI's or our affiliates' customers in the 12
months immediately preceding termination or solicit persons who were our or our
affiliates' prospective customers (as defined) at the time of termination, and
this is now without regard of the reason for termination.
· provides that while he is employed and for two years thereafter he will not
induce employees to leave JCPI's employment, hire or employ any person who was
JCPI's or JCPI's affiliates' employee within 12 months of his termination,
induce any of our or our affiliates' customers, clients, suppliers or business
relations to cease doing business with JCPI or its affiliates (if such persons
were customers, clients or suppliers in the 12 month period preceding his
termination), and this is now without regard to the reason for termination.
The Amendment also continues to provide for numerous provisions which are
identical to or materially consistent with the Employment Agreement, including
the following, among others:
· continues to provide Mr. Delaney a miscellaneous allowance of $20,000 per year
(subject to proration for partial calendar years).
· continues to provide Mr. Delaney an automobile allowance of a maximum of
$18,000 per annum.
· provides for a performance linked bonus of up to 75% of Mr. Delaney's base
salary, similar to the bonus under the Employment Agreement. Mr. Delaney is
generally eligible for a 40% bonus once he achieves 90% of his targets and an
additional 1% bonus for each additional percentage of targets reached (up to
125% of targets).
· As in the Employment Agreement, provides for Severance Pay (as defined below)
payable over a six (6) month period (but if Mr. Delany is a "specified
employee" under Internal Revenue Code Section 4099A then any Severance Pay
considered nonqualified deferred compensation under Internal Revenue Code
Section 409A payable on account of separation from service shall be paid six
months from such separation, in a lump sum). Severance Pay is payable in the
event the Employment Agreement is terminated by JCPI without cause, or by Mr.
Delaney for Good Reason, and consists of up to six months of his then current
base salary in effect immediately prior to the date of termination, a bonus
equal to the average annual performance bonus paid over the preceding three
years (pro-rated until the date of termination) and retention bonuses on a
prorated monthly basis until the date of termination (collectively, "Severance
Pay"), provided that Severance Pay is reduced on a dollar for dollar basis in
the amount equal to the amount of salary payable to Mr. Delaney by another
employer during the period of the payment of the Severance Pay. Good Reason
includes a change of control, a reduction in duties which are inconsistent with
Mr. Delaney's position as Chief Executive Officer or a reduction in Mr.
Delaney's salary, bonus or other benefits (unless such benefits are similarly
reduced for other Company executives) that are not agreed to by Mr. Delaney.
· continues to provide that JCPI will provide for the cost of medical and dental
coverage premiums for Mr. Delaney and his dependents for a six (6) month period
· continues to restrict Mr. Delaney from competing with JCPI for six months after
termination.(other than on a non-renewal of the Employment Agreement, as
amended by the Company).
· continues to restrict Mr. Delaney from disclosing, disseminating or using for
his personal benefit or for the benefit of others, confidential or proprietary
information, and from competing with us at any time prior to six months after
the termination of his employment with us (except that the non-compete does not
apply if we do not renew his agreement at the end of the term).
Item 9.01 Financial Statements and Exhibits
Exhibit Number Description
10.1 Amended and Restated Employment Agreement of Scott Delaney
executed on August 4, 2014 and August 6, 2014.
[ Back To Technology News's Homepage ]